Filing Details

Accession Number:
0001209191-16-106791
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-07 20:44:08
Reporting Period:
2016-03-04
Filing Date:
2016-03-07
Accepted Time:
2016-03-07 20:44:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654482 Mohammad Hirmand C/O Medivation, Inc.
525 Market St., 36Th Floor
San Francisco CA 94105
Interim Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-03-04 1,525 $41.10 39,342 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
  2. The shares were sold at prices between $41.0981 and $41.115. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Includes 454 shares purchased through the issuer's ESPP.